Actively Recruiting
Evaluation of MRI-conditional 12-lead ECG
Led by Dr. Graham Wright · Updated on 2025-05-29
40
Participants Needed
1
Research Sites
362 weeks
Total Duration
On this page
AI-Summary
What this Trial Is About
With MRI's increasing role in detecting central nervous system and orthopedic diseases, patients with ischemic history are increasingly referred for MRI exams. Currently, 3-lead ECG gating systems are utilized during cardiac MRI scanning as standard of care. However, this monitoring system is often insufficient to evaluate for the development of important arrhythmias or ischemia during MRI scanning. Morevoer, MRI associated magnetic fields and radio frequency pulses can produce interference in the ECG signal that leads to non-diagnostic ECG signals. MiRTLE Medical, a Massachusetts-based medical device company, has developed a high-fidelity, MRI-conditional 12-lead ECG monitoring system. This 12-lead ECG system is a first of its kind that addresses the MRI-induced interference and safety issues. This study is to evaluate the efficacy of this 12-lead ECG system in the clinical setting. The investigators hope that this system will be helpful for image-guided therapeutics especially electrophysiology.
CONDITIONS
Official Title
Evaluation of MRI-conditional 12-lead ECG
Who Can Participate
Eligibility Criteria
You may qualify if you...
- 18 years of age and older
- Diagnosed with atrial fibrillation
- Able to provide informed consent
- Eligible for the Ontario Health Insurance Plan
You will not qualify if you...
- Unable or unwilling to provide informed consent
- Pregnant women
- Contraindications to cardiac magnetic resonance imaging (CMR)
- Hemodynamically unstable
- Presence of a permanent pacemaker or implantable cardioverter defibrillator (ICD)
- Presence of aneurysm clip or carotid artery vascular clamp
- Claustrophobia preventing MRI
AI-Screening
AI-Powered Screening
Complete this quick 3-step screening to check your eligibility
Trial Site Locations
Total: 1 location
1
Sunnybrook Health Sciences Center
Toronto, Ontario, Canada, M4N 3M5
Actively Recruiting
Research Team
M
Mary Li, MSc
CONTACT
How is the study designed?
Study Type
INTERVENTIONAL
Masking
NONE
Allocation
NON_RANDOMIZED
Model
PARALLEL
Primary Purpose
OTHER
Number of Arms
2
Not the Right Trial for You?
Explore thousands of other clinical trials that might be a better match.
Sign up to get personalized trial recommendations delivered to your inbox.
Already have an account? Log in here